On our screens:Cheap stocks by free cash flow yield
What is the market doing?
What the tape says about OGN
Organon & Co. is +49% over the past year while the S&P 500 is +20%: 29 points ahead of the market.
+49%
1-year return · S&P 500 +20%
- vs 200-day average
- +39%
vs 200-day average · a clear uptrend
- RSI (14)
- 64
RSI (14) · neutral
- Below its 52-week high
- 0.22%
Below its 52-week high
Details›
- Last close2026-09-08
- $13.75
- 1 monthS&P 500 −0.30%
- +1.6%
- 1 yearS&P 500 +20%
- +49%
- 5 yearsS&P 500 +85%
- −44%
- vs 50-day average$13.59
- +1.2%
- 52-week high
- $13.78
- 52-week low
- $5.69
- Annualised volatility
- 61%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$353K
| Year | Return |
|---|---|
| 2026 (year to date) | +93% |
| 2025 | −51% |
| 2024 | +9.9% |
| 2023 | −45% |
| 2022 | −4.9% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 5 of 5 | +10% |
| Feb | 5 | 2 of 5 | −2.1% |
| Mar | 5 | 1 of 5 | −4.1% |
| Apr | 5 | 2 of 5 | +21% |
| May | 5 | 3 of 5 | −2.7% |
| Jun | 6 | 3 of 6 | −2.7% |
| Jul | 6 | 4 of 6 | +0.28% |
| Aug | 6 | 4 of 6 | +2.1% |
| Sep | 6 | 1 of 6 | −7.2% |
| Oct | 5 | 2 of 5 | −5.9% |
| Nov | 5 | 2 of 5 | −8.0% |
| Dec | 5 | 3 of 5 | +5.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #7 of 7 by Smart Score